Ani Pharmaceuticals Inc financial data

Symbol
ANIP on Nasdaq
Location
210 Main Street West, Baudette, MN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 262 % -25%
Quick Ratio 61.9 % -24%
Debt-to-equity 198 % +58.2%
Return On Equity 9.2 %
Return On Assets 3.05 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 1.2B USD +45.6%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 20.1M shares +3.45%
Weighted Average Number of Shares Outstanding, Diluted 21.1M shares +8.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 827M USD +48.9%
Research and Development Expense 56M USD +48.3%
Costs and Expenses 755M USD +38.8%
Operating Income (Loss) 71.9M USD +516%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 50.6M USD
Income Tax Expense (Benefit) 9.98M USD
Net Income (Loss) Attributable to Parent 40.6M USD
Earnings Per Share, Basic 1 USD/shares
Earnings Per Share, Diluted 1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 263M USD +81.1%
Accounts Receivable, after Allowance for Credit Loss, Current 253M USD +28.6%
Inventory, Net 146M USD -1.06%
Assets, Current 698M USD +34%
Deferred Income Tax Assets, Net 71.4M USD +5.52%
Property, Plant and Equipment, Net 63.6M USD +12.1%
Operating Lease, Right-of-Use Asset 5.2M USD
Intangible Assets, Net (Excluding Goodwill) 500M USD -12.3%
Goodwill 62.5M USD +3.4%
Other Assets, Noncurrent 12.5M USD +9.01%
Assets 1.41B USD +9.38%
Accounts Payable, Current 69.8M USD +14.6%
Employee-related Liabilities, Current 33.2M USD +11.6%
Accrued Liabilities, Current 14M USD -21.7%
Contract with Customer, Liability, Current 5M USD
Liabilities, Current 271M USD +42.4%
Operating Lease, Liability, Noncurrent 4.39M USD +6.86%
Other Liabilities, Noncurrent 11.3M USD +62.3%
Liabilities 902M USD +5.34%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.81M USD -47.6%
Retained Earnings (Accumulated Deficit) -50.6M USD +43.5%
Stockholders' Equity Attributable to Parent 506M USD +24.6%
Liabilities and Equity 1.41B USD +9.38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 35M USD +91.5%
Net Cash Provided by (Used in) Financing Activities -9.91M USD +49.8%
Net Cash Provided by (Used in) Investing Activities -19.8M USD -322%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.94M USD -33.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 263M USD +81.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.9M USD +11.9%
Deferred Tax Assets, Valuation Allowance 9.5M USD +2275%
Deferred Tax Assets, Gross 121M USD +18.1%
Operating Lease, Liability 5.2M USD
Payments to Acquire Property, Plant, and Equipment 2.47M USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 38M USD
Lessee, Operating Lease, Liability, to be Paid 7.21M USD +8.29%
Property, Plant and Equipment, Gross 77.5M USD +2.07%
Operating Lease, Liability, Current 1.8M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.78M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.08M USD +5.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.02M USD +3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD +39%
Deferred Tax Assets, Operating Loss Carryforwards 27.3M USD +840%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.67M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.02M USD -20.6%
Additional Paid in Capital 586M USD +14.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 82.6M USD +55%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%